Sweden · Delayed Price · Currency is SEK OrganoClick AB Statistics
Total Valuation
OrganoClick AB has a market cap or net worth of SEK 38.94 million. The enterprise value is 121.65 million.
| Market Cap | 38.94M |
| Enterprise Value | 121.65M |
Important Dates
The last earnings date was Wednesday, August 12, 2026.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OrganoClick AB has 110.00 million shares outstanding. The number of shares has increased by 9.90% in one year.
| Current Share Class | 110.00M |
| Shares Outstanding | 110.00M |
| Shares Change (YoY) | +9.90% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 39.36% |
| Owned by Institutions (%) | 14.33% |
| Float | 46.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.43 |
| PB Ratio | 2.57 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.42, with a Debt / Equity ratio of 5.18.
| Current Ratio | 0.42 |
| Quick Ratio | 0.16 |
| Debt / Equity | 5.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | -14.42 |
| Interest Coverage | -2.86 |
Financial Efficiency
Return on equity (ROE) is -155.66% and return on invested capital (ROIC) is -12.84%.
| Return on Equity (ROE) | -155.66% |
| Return on Assets (ROA) | -8.56% |
| Return on Invested Capital (ROIC) | -12.84% |
| Return on Capital Employed (ROCE) | -60.11% |
| Weighted Average Cost of Capital (WACC) | 7.63% |
| Revenue Per Employee | 2.74M |
| Profits Per Employee | -975,424 |
| Employee Count | 33 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 2.61 |
Taxes
In the past 12 months, OrganoClick AB has paid 70,000 in taxes.
| Income Tax | 70,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.66% in the last 52 weeks. The beta is 0.77, so OrganoClick AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -80.66% |
| 50-Day Moving Average | 0.42 |
| 200-Day Moving Average | 1.04 |
| Relative Strength Index (RSI) | 43.37 |
| Average Volume (20 Days) | 282,616 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OrganoClick AB had revenue of SEK 90.28 million and -32.19 million in losses. Loss per share was -0.30.
| Revenue | 90.28M |
| Gross Profit | 20.01M |
| Operating Income | -20.54M |
| Pretax Income | -33.71M |
| Net Income | -32.19M |
| EBITDA | -15.78M |
| EBIT | -20.54M |
| Loss Per Share | -0.30 |
Balance Sheet
The company has 480,000 in cash and 78.56 million in debt, with a net cash position of -78.08 million or -0.71 per share.
| Cash & Cash Equivalents | 480,000 |
| Total Debt | 78.56M |
| Net Cash | -78.08M |
| Net Cash Per Share | -0.71 |
| Equity (Book Value) | 15.17M |
| Book Value Per Share | 0.10 |
| Working Capital | -59.05M |
Cash Flow
In the last 12 months, operating cash flow was -4.03 million and capital expenditures -1.41 million, giving a free cash flow of -5.45 million.
| Operating Cash Flow | -4.03M |
| Capital Expenditures | -1.41M |
| Depreciation & Amortization | 4.76M |
| Net Borrowing | -7.57M |
| Free Cash Flow | -5.45M |
| FCF Per Share | -0.05 |
Margins
Gross margin is 22.16%, with operating and profit margins of -22.75% and -35.66%.
| Gross Margin | 22.16% |
| Operating Margin | -22.75% |
| Pretax Margin | -37.33% |
| Profit Margin | -35.66% |
| EBITDA Margin | -17.48% |
| EBIT Margin | -22.75% |
| FCF Margin | n/a |
Dividends & Yields
OrganoClick AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.90% |
| Shareholder Yield | -9.90% |
| Earnings Yield | -82.66% |
| FCF Yield | -13.99% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OrganoClick AB has an Altman Z-Score of -2.85 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.85 |
| Piotroski F-Score | 3 |